## **Core Concept**
Non-competitive inhibition is a type of enzyme inhibition where the inhibitor binds to an allosteric site on the enzyme, altering its shape and affecting its activity, regardless of the substrate binding. This type of inhibition reduces the maximum velocity (Vmax) of the enzymatic reaction without affecting the affinity of the enzyme for the substrate, which is reflected in the Michaelis constant (Km).

## **Why the Correct Answer is Right**
In non-competitive inhibition, the inhibitor binds to a region of the enzyme other than the active site, called an allosteric site. This binding causes a conformational change in the enzyme structure, which reduces its activity. The key characteristics of non-competitive inhibition are that it decreases the Vmax of the enzyme and does not change the Km, as the substrate and inhibitor do not compete for the same site. This matches option .

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because competitive inhibition involves the inhibitor competing with the substrate for the active site on the enzyme, increasing Km but not affecting Vmax.
- **Option B:** This option is incorrect because uncompetitive inhibition involves the inhibitor binding to the enzyme-substrate complex, decreasing both Km and Vmax.
- **Option C:** This option is incorrect because it describes a mix of effects not characteristic of non-competitive inhibition.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that non-competitive inhibitors can be used therapeutically to regulate enzyme activity. For example, the drug aspirin acts as a non-competitive inhibitor of the enzyme cyclooxygenase (COX), which is involved in the synthesis of prostaglandins, thereby exerting its anti-inflammatory and analgesic effects.

## **Correct Answer:** .